Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
₹ 21.8
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Very low or no dividends
Data is available to registered users only
Data is available to registered users only
About
Beryl Drugs Ltd. engages in the manufacture of bulk drugs. It offers small volume injectables in liquid and dry form, eye and ear drops, Intravenous fluids in polypack and glass bottles and veterinary medicines. The company was founded on August 24, 1993 and is headquartered in Indore, India.
Company Valuation
Based on key historical and expected multiples, the stock is fairly valued relative to its peers. In particular, the stock is overpriced on P/E, 'cheap' on EV/EBITD.
Data is available to registered users only
Buy
Sell